Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer

NCT03998566 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DEVICE: TraceIT Tissue Spacer implantation

Sponsor

Boston Scientific Corporation